Intergenerational mHealth Diabetes Program OPPORTUNITIES PROGRAM IN TAIWAN (IMTOP)
Type 2 Diabetes Mellitus

About this trial
This is an interventional health services research trial for Type 2 Diabetes Mellitus focused on measuring Integeneration, Mobile technology, Chronic disease management, Diabetes self-management
Eligibility Criteria
Inclusion Criteria:
Older adult subjects inclusion criteria are:
- current Taipei or Hualien Tzu Chi patients
- aged equal to or greater than 55 years
- having a current diagnosis of type 2 diabetes mellitus with duration of diagnosis at least 6 months
- having the ability of reading Chinese newspaper
- normal eye-hand coordination
- being able to regularly attend the IMTOP training course
- understanding Mandarin (listening, speaking, reading, and writing).
- having a working telephone at home or a cellular phone.
Younger adult subjects inclusion criteria are:
- age between 18 and 30
- having basic levels of verbal, interpersonal communication, and computer skills and commitment in voluntary works for approximately 50 hours during the period of intervention.
Exclusion Criteria:
Older adult subjects exclusion criteria are:
- a score of 2 or greater on the CAGE 4M alcohol assessment;
- having schizophrenia, schizoaffective disorder, manic-depressive, or needing lithium;
- cognitive impairment precluding ability to give informed consent or participating in the intervention, i.e., SPMSQ score of 4 or more errors.
Younger adult subjects exclusion criteria are:
- age less than 18 or above 30
- being unfamiliar with computer
- being unable to commit 50 hours during the period of intervention
Sites / Locations
- HualienTzu Chi Hospital
- Taipei Tzu Chi Hospital
Arms of the Study
Arm 1
Arm 2
Experimental
Other
Immediate intervention group
Waitlist control group
A randomized, waitlist controlled trial with three hundred fifty older adult subjects with type 2 diabetes and 280 young adult subjects will be conducted in Taipei Tzu Chi Hospital and Hualien Tzu Chi Hospital in Taiwan. The patients who are randomized to the immediate intervention group will be assigned to the training course as soon as a course is available. The intervention is a 12-week program which consists of 8-week training sessions followed by 4-week consultation service for technical support. Both will be provided by the young volunteers with a lead instructor.
The patients randomized to the waitlist control group will need to wait for four months to serve as no intervention control, and then assigned to the training course.